title: CHEK2*1100delC and male breast cancer risk in Israel.
authors.forename: Tal
authors.initials: T
authors.lastname: Ohayon
authors.forename: Inbar
authors.initials: I
authors.lastname: Gal
authors.forename: Ruth Gershoni
authors.initials: RG
authors.lastname: Baruch
authors.forename: Csilla
authors.initials: C
authors.lastname: Szabo
authors.forename: Eitan
authors.initials: E
authors.lastname: Friedman
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018567:Breast Neoplasms, Male / Q000201:enzymology / Q000453:epidemiology / Q000235:genetics*; D064447:Checkpoint Kinase 2; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D007557:Israel / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D012307:Risk Factors; D017384:Sequence Deletion
chemical_list: D064447:Checkpoint Kinase 2; C578634:CHEK2 protein, human; D017346:Protein Serine-Threonine Kinases